Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 80255 BALTIMORE, MD
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,606,588
+$918,586 QoQ
Shares Held
145,133
+19.5% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 207 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $2,378,351,093 across 40 Drug Manufacturers - Specialty & Generic names. AMLX ranks #18 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 68,214,436 $1,083,245,243
2 ALKS
Alkermes plc.
 6,737,328 $353,035,986
3 LNTH
Lantheus Holdings, Inc.
 1,903,354 $211,158,092
4 LQDA
Liquidia Corp
 1,940,364 $154,705,221
5 UTHR
UNITED THERAPEUTICS Corp
 243,444 $131,905,262
6 PRGO
PERRIGO Co plc
 8,700,421 $90,397,373
7 ZTS
Zoetis Inc.
 1,139,097 $81,855,510
8 TEVA
Teva Pharmaceutical Industries Ltd
 1,679,152 $56,889,668

All Filings in AMLX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,606,588 145,133
2026-03-31 $1,688,002 121,439
2025-12-31 $1,299,179 107,548
2025-09-30 $1,365,047 100,445
2025-06-30 $585,822 91,392
2025-03-31 $204,258 57,700
2024-12-31 $218,106 57,700
2024-09-30 $180,144 55,600
2024-06-30 $105,640 55,600
2024-03-31 $2,756,375 970,555
2023-12-31 $13,171,161 894,780
2023-09-30 $443,468 24,220
2023-06-30 $498,008 23,088
2023-03-31 $660,355 22,507
2022-12-31 $579,486 15,683